These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30668168)

  • 1. Living with Ménière's disease: an interpretative phenomenological analysis.
    Talewar KK; Cassidy E; McIntyre A
    Disabil Rehabil; 2020 Jun; 42(12):1714-1726. PubMed ID: 30668168
    [No Abstract]   [Full Text] [Related]  

  • 2. People with symptoms of Ménière's disease: the relationship between illness intrusiveness, illness uncertainty, dizziness handicap, and depression.
    Arroll M; Dancey CP; Attree EA; Smith S; James T
    Otol Neurotol; 2012 Jul; 33(5):816-23. PubMed ID: 22705835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing quality of life in patients with Ménière's disease, identified by a multidimensional approach.
    Söderman AC; Bagger-Sjöbäck D; Bergenius J; Langius A
    Otol Neurotol; 2002 Nov; 23(6):941-8. PubMed ID: 12438860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental Health and Subjective Well-being of Individuals With Ménière's: Cross-sectional Analysis in the UK Biobank.
    Tyrrell J; White MP; Barrett G; Ronan N; Phoenix C; Whinney DJ; Osborne NJ
    Otol Neurotol; 2015 Jun; 36(5):854-61. PubMed ID: 25730447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Qualitative Study on the Experience of Patients with Meniere Disease].
    Joung WJ
    J Korean Acad Nurs; 2020 Oct; 50(5):699-713. PubMed ID: 33142301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional, virtual reality vestibular rehabilitation for chronic imbalance problem caused by Ménière's disease: a pilot study.
    Hsu SY; Fang TY; Yeh SC; Su MC; Wang PC; Wang VY
    Disabil Rehabil; 2017 Aug; 39(16):1601-1606. PubMed ID: 27418422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Ménière's Disease on Significant Others' Health and Lives.
    Manchaiah V; Pyykkő I; Levo H; Kentala E
    J Am Acad Audiol; 2018 Jan; 29(1):63-72. PubMed ID: 29309024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported effects of Ménière's disease on the individual's life: a qualitative analysis.
    Stephens D; Pyykko I; Varpa K; Levo H; Poe D; Kentala E
    Otol Neurotol; 2010 Feb; 31(2):335-8. PubMed ID: 19841603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A day in the life of a Ménière's patient: understanding the lived experiences and mental health impacts of Ménière's disease.
    Bell SL; Tyrrell J; Phoenix C
    Sociol Health Illn; 2017 Jun; 39(5):680-695. PubMed ID: 27910108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive experiences associated with Ménière's disorder.
    Stephens D; Kentala E; Varpa K; Pyykkö I
    Otol Neurotol; 2007 Oct; 28(7):982-7. PubMed ID: 17577129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.
    Ward B; Wettstein V; Golding J; Corallo G; Nuti D; Trabalzini F; Mandala M
    J Int Adv Otol; 2019 Apr; 15(1):112-117. PubMed ID: 31058600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Ménière's disease on quality of life.
    Anderson JP; Harris JP
    Otol Neurotol; 2001 Nov; 22(6):888-94. PubMed ID: 11698814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vestibular rehabilitation in the treatment of Meniere's disease.
    Gottshall KR; Hoffer ME; Moore RJ; Balough BJ
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):326-8. PubMed ID: 16143175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life instruments in Ménière's disease.
    Green JD; Verrall A; Gates GA
    Laryngoscope; 2007 Sep; 117(9):1622-8. PubMed ID: 17667131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom severity, social supports, coping styles, and quality of life among individuals' diagnosed with Ménierè's disease.
    Porter M; Boothroyd RA
    Chronic Illn; 2015 Dec; 11(4):256-66. PubMed ID: 25595277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
    Aoki M; Asai M; Nishihori T; Mizuta K; Ito Y; Ando K
    J Neuroendocrinol; 2007 Nov; 19(11):901-6. PubMed ID: 17927668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ICF in assessing the effects of Meniere's disorder on life.
    Levo H; Stephens D; Poe D; Kentala E; Pyykkö I
    Ann Otol Rhinol Laryngol; 2010 Sep; 119(9):583-9. PubMed ID: 21033024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.